A common feature of schizophrenia is difficulty using new information to understand the world. This challenge can make decision-making harder and, over time, may contribute to a disconnect from reality. Researchers at MIT have identified a gene mutation that may play a key role in this problem. In experiments with mice, they found that the mutation disrupts a brain circuit responsible for updating beliefs when new information is received.
Unraveling the Genetic Roots of Schizophrenia
Schizophrenia, a complex and often debilitating mental health condition, affects approximately 1% of the global population. The disorder is characterized by a range of symptoms, including hallucinations, delusions, disorganized thinking, and significant impairments in cognitive function. While the exact causes remain multifaceted, scientific consensus points to a substantial genetic predisposition, with familial history dramatically increasing an individual’s risk. For instance, the likelihood of developing schizophrenia rises to 10% if a parent or sibling is diagnosed, and to a striking 50% for identical twins, underscoring the profound influence of genetics.
For years, researchers have been meticulously piecing together the genetic landscape of schizophrenia. Large-scale genome-wide association studies (GWAS), such as those conducted by the Stanley Center for Psychiatric Research at the Broad Institute, have been instrumental in identifying over 100 gene variants associated with an increased risk of the disorder. However, a significant challenge has emerged: many of these identified variants reside in non-coding regions of DNA, the vast expanse of genetic material not directly translated into proteins. This location makes it exceptionally difficult to pinpoint their precise functional impact on brain health and disease development.
To overcome this interpretational hurdle, scientists have increasingly turned to more refined genetic analysis techniques. Whole-exome sequencing, a method that specifically focuses on the protein-coding regions of the genome – the exome – has emerged as a powerful tool. This targeted approach allows researchers to directly identify mutations within genes that are responsible for producing the proteins that carry out essential cellular functions. By analyzing a substantial dataset comprising around 25,000 sequences from individuals diagnosed with schizophrenia and a control group of 100,000 individuals, researchers have successfully pinpointed 10 specific genes where mutations are strongly correlated with a significantly elevated risk of developing the disorder. This new study zeroes in on one of these critical genes, grin2a.
The GRIN2A Gene and its Role in Belief Updating
The focus of this groundbreaking research is the grin2a gene, a gene previously flagged in large-scale genetic studies of schizophrenia for its potential link to the disorder. The grin2a gene plays a crucial role in the production of a subunit of the NMDA receptor, a vital component of neuronal communication. NMDA receptors are activated by glutamate, a primary excitatory neurotransmitter in the brain, and are widely distributed on neurons throughout the central nervous system. These receptors are fundamental to processes such as learning, memory, and synaptic plasticity – the brain’s ability to adapt and change in response to experience.
The study, published in the prestigious journal Nature Neuroscience, was led by Tingting Zhou, a research scientist at MIT’s McGovern Institute, and Yi-Yun Ho, a former MIT postdoctoral fellow. Guoping Feng, the James W. and Patricia T. Poitras Professor in Brain and Cognitive Sciences at MIT and a member of the Broad Institute, and Michael Halassa, an associate professor of psychiatry and neuroscience at Tufts University, served as the senior authors. Their collaborative efforts have illuminated a specific mechanism by which a grin2a mutation can contribute to the cognitive hallmarks of schizophrenia.
"If this circuit doesn’t work well, you cannot quickly integrate information," explained Professor Feng. "We are quite confident this circuit is one of the mechanisms that contributes to the cognitive impairment that is a major part of the pathology of schizophrenia." This statement highlights the central hypothesis of the research: that disruptions in the brain’s ability to dynamically update its understanding of the world based on new sensory input are a core deficit in schizophrenia, and that the grin2a gene is intimately involved in this process.
A Mouse Model Reveals Deficits in Adaptive Decision-Making
To investigate the functional consequences of a grin2a mutation, the research team engineered mice to carry this specific genetic alteration. While the complex subjective experiences of psychosis, such as hallucinations and delusions, cannot be directly replicated in animal models, scientists can effectively study related cognitive processes. One such process is the ability to interpret and integrate new sensory information, a function that is profoundly impaired in individuals with schizophrenia.
For decades, researchers have theorized that psychosis may stem from a diminished capacity to update one’s internal model of reality when confronted with new evidence. Dr. Zhou elaborated on this concept, stating, "Our brain can form a prior belief of reality, and when sensory input comes into the brain, a neurotypical brain can use this new input to update the prior belief. This allows us to generate a new belief that’s close to what the reality is. What happens in schizophrenia patients is that they weigh too heavily on the prior belief. They don’t use as much current input to update what they believed before, so the new belief is detached from reality." This "belief updating" deficit is thought to underpin the disconnect from reality experienced by many with schizophrenia.
To experimentally test this hypothesis in their genetically modified mice, Zhou and colleagues devised a sophisticated behavioral task. The mice were trained to choose between two levers, each offering a different reward structure. One lever provided a low reward, requiring six presses to yield a single drop of milk. The other offered a higher reward, delivering three drops of milk per press. Initially, all mice, irrespective of their genetic makeup, gravitated towards the high-reward lever. However, as the experiment progressed, the effort required to obtain the high reward gradually increased, while the low-reward lever’s output remained constant.
In this dynamic environment, neurotypical mice demonstrated remarkable adaptability. As the effort for the high-reward option began to approach the effort required for the low-reward option, they intelligently switched their preference and consistently chose the more efficient, lower-effort lever. This behavior reflects a healthy ability to update their internal assessment of reward value based on changing environmental conditions.
In stark contrast, the mice carrying the grin2a mutation exhibited significantly impaired adaptive decision-making. They continued to oscillate between the levers for a prolonged period, delaying their commitment to the more advantageous choice even when the effort levels became comparable. "We find that neurotypical animals make adaptive decisions in this changing environment," Zhou observed. "They can switch from the high-reward side to the low-reward side around the equal value point, while for the animals with the mutation, the switch happens much later. Their adaptive decision-making is much slower compared to the wild-type animals." This delayed behavioral adjustment in the mutant mice provides compelling evidence that the grin2a mutation impairs the brain’s ability to update its expectations and adapt its behavior in response to new information.
Pinpointing the Neural Circuitry: The Mediodorsal Thalamus
The behavioral observations in the mice spurred the researchers to investigate the underlying neural mechanisms. Employing advanced techniques such as functional ultrasound imaging and precise electrical recordings, the team identified a critical brain region as the primary locus of the mutation’s impact: the mediodorsal thalamus. This region is a key hub within the brain’s intricate network, playing a pivotal role in relaying sensory and motor information to the cerebral cortex.
Specifically, the mediodorsal thalamus forms a crucial connection with the prefrontal cortex, a brain area essential for higher-order cognitive functions including decision-making, planning, and executive control. This interconnected pathway, known as the thalamocortical circuit, is fundamental to our ability to engage in goal-directed behavior and adapt to our surroundings. The researchers observed that neurons within the mediodorsal thalamus of the mutant mice exhibited altered activity patterns. These neurons appeared to be less efficient in tracking changes in the perceived value of different choices, a function vital for adaptive decision-making. Furthermore, distinct patterns of neural activity were noted depending on whether the mice were actively exploring potential rewards or had committed to a specific choice, suggesting a disruption in the neural coding of these decision-making states.
Restoring Function: A Glimmer of Hope for Treatment
Perhaps the most exciting aspect of this research is the demonstration that the cognitive deficits induced by the grin2a mutation can be reversed. Using a sophisticated technique called optogenetics, the researchers engineered neurons in the mediodorsal thalamus of the mutant mice to become responsive to light. By selectively activating these specific neurons with precisely timed light pulses, they were able to restore normal behavioral patterns. The mice, when their mediodorsal thalamus neurons were optogenetically stimulated, began to make adaptive decisions more akin to their genetically unaltered counterparts.
This remarkable finding opens up a significant avenue for future therapeutic interventions. While mutations in the grin2a gene are found in only a subset of individuals with schizophrenia, the researchers propose that the dysfunction in the identified thalamocortical circuit might represent a shared underlying mechanism contributing to the cognitive impairments observed in a broader range of patients. This suggests that targeting this specific neural pathway could potentially alleviate some of the most persistent and challenging symptoms of schizophrenia.
The research team is now actively engaged in the next phase of their work: identifying the specific molecular components within this circuit that could be targeted by pharmacological agents. The goal is to develop medications that can modulate the activity of this pathway, thereby improving cognitive function and enhancing the quality of life for individuals affected by schizophrenia.
Funding and Future Implications
This pioneering research was supported by substantial funding from several esteemed institutions, including the National Institute of Mental Health, the Poitras Center for Psychiatric Disorders Research at MIT, the Yang Tan Collective at MIT, the K. Lisa Yang and Hock E. Tan Center for Molecular Therapeutics at MIT, the Stelling Family Research Fund at MIT, the Stanley Center for Psychiatric Research, and the Brain and Behavior Research Foundation. This broad support underscores the scientific community’s recognition of the critical importance of understanding the neurobiological underpinnings of severe mental illnesses.
The implications of these findings extend far beyond the specific grin2a gene. This study provides a powerful example of how basic neuroscience research, by dissecting complex cognitive processes at the molecular and circuit level, can yield profound insights into the mechanisms of psychiatric disorders. The identification of the mediodorsal thalamus-prefrontal cortex circuit as a key player in belief updating offers a concrete target for future drug development. As the research progresses, it holds the promise of leading to novel treatments that address the cognitive deficits of schizophrenia, a persistent unmet need in the field of mental health. The journey from identifying a gene variant to understanding its impact on brain circuits and behavior is a testament to the power of interdisciplinary scientific inquiry and offers renewed hope for individuals and families affected by this challenging condition.